In cooperation with the G7 Research Group and G20 Research Group

Duff & Phelps
LIVE UPDATES

Share
    18-May-2017 04:57 PM

    And that's a wrap!

    And thus ends a fantastic day of the B20 Health Summit in Berlin, where much was shared and learned. Well done to everyone involved for putting on such an informative and important conference. Looking forward to taking the steps proposed today.


    18-May-2017 04:53 PM

    Important remark from Kemal Malik

    Very important remark on innovation in health systems by Kemal Malik, Member of the Board of Management at Bayer AG. 

    18-May-2017 03:56 PM

    Closing discussion: how to improve health systems by innovative solutions


    Lessons Learned from the Workshops – Reports by the Chairs:

    • Benjamin Grosch, Partner & Managing Director Berlin, Boston Consulting Group
    • Joseph Ndung’u, Head of Neglected Tropical Diseases, FIND
    • Peter Sands, Harvard Kennedy School and Chair of World Bank’s International Working Group on Financing Pandemic Preparedness
    • Walter Märzendorfer, President Diagnostic Imaging, Siemens Healthineers
    • Roland Göhde, Chairman, German Healthcare Partnership
    • Kemal Malik, Member of the Board of Management, Bayer AG

    Moderated by Stormy-Annika Mildner, B20 Germany Sherpa

    18-May-2017 03:26 PM

    Driving innovation in Alzheimer's treatment at the B20 Health Conference

    Scientific innovation to address mental and neurological disorders such as Alzheimer’s is extremely challenging, with therapies requiring more time to obtain regulatory approval compared with medicines for treating other diseases. These diseases alone affect more than one third of the world’s population and result in nearly $1 trillion lost in economic productivity and a heavy burden on health systems, caregivers, and families. G20 members need to lay out incentives for research in mental and neurological disorders, support new research partnerships, care models, and public health campaign to address these diseases holistically.

    18-May-2017 02:56 PM

    Sixth afternoon workshop at the B20 Health Conference

    A discussion on innovation at the heart of the debate: improving health and well-being for an active generation. Chaired by Kemal Malik, Member of the Board of Management, Bayer AG, with discussants:

    • Harald Nusser, Head Social Business, Novartis
    • Patrick Holmes, Head International Policy, Global Policy and International Public Affairs, Pfizer
    • Erwin Böttinger, CEO, Berlin Institute of Healt
    18-May-2017 02:49 PM

    Fifth afternoon workshop at the B20 Health Conference

    A discussion on global health: improved access to medical care chaired by Roland Göhde, Chairman, German Healthcare Partnership, with discussants:

    • Nicole Denjoy, COCIR Secretary General, OECD
    • Gregg H. Alton, Executive Vice President, Corporate and Medical Affairs, Gilead Sciences
    • Pradeep Kakkattil, Director Partnerships, Innovations and Fundraising, UNAIDS
    18-May-2017 02:39 PM

    Fourth afternoon workshop at the B20 Health Conference

    Discussion on the role of digital health chaired by Walter Märzendorfer, President Diagnostic Imaging, Siemens Healthineers, with discussant:

    • Carla Kriwet, Executive Vice President, Philips
    • Michael Lorsbach, Chief Executive Officer, Alcedis GmbH

    18-May-2017 02:35 PM

    Third afternoon workshop at the B20 Health Conference

    Discussion on improving pandemic preparedness and response chaired by Frank Gotthardt,Peter Sands, Harvard Kennedy School and Chair of World Bank’s International Working Group on Financing Pandemic Preparedness , with discussants:

    • Byungki Oh, Vice President of Global Business Development Korea Telecom
    • Arnaud Bernaert, Head of Global Health and Healthcare Industries, World Economic Forum
    • Irmgard Buchkremer, Head of Pharmaceutical Department and Quality Assurance
    18-May-2017 02:21 PM

    Second afternoon workshop at the B20 Health Conference

    Discussion on eliminating Neglected Tropical Diseases by 2020 chaired by Frank Gotthardt, Head of Public Affairs & Corporate Responsibility, Merck, with discussants:

    • Alan Donnelly, Executive Chairman, Sovereign Strategy
    • Joseph Ndung’u, Head of Neglected Tropical Diseases, FIND
    • Sami Al-Hajjar, President, Saudi Commission for Health Specialties

    18-May-2017 02:17 PM

    First afternoon workshop at the B20 Health Conference

    Discussion on antimicrobial resistance chaired by Benjamin Grosch, Partner & Managing Director Berlin, Boston Consulting Group, with discussants:

    • Thomas B. Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations
    • Manica Balasegaram, Director, GARDP Operations, DNDi
    • Rachael Crockett, Chair for Global Health, C20 Germany